Clinical Trials

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT03624036 2023-11-18

ZUMA-8

Phase 1 Terminated

16 enrolled 17 charts

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04245722 2023-10-26

FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies

Phase 1 Terminated

98 enrolled

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT05244070 2023-07-18

A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 1 Terminated

5 enrolled

Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT04030195 2023-01-31

Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL

Phase 1/2 Completed

18 enrolled 13 charts

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT01905943 2019-10-28

A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia

979 enrolled 16 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01283386 2019-03-14

A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Participants With Chronic Lymphocytic Leukemia and Unfavorable Somatic Status

Phase 4 Terminated

26 enrolled 13 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00545714 2019-01-16

A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocytic Leukemia (CLL)

86 enrolled 15 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01292603 2018-12-19

A Study to Compare Subcutaneous Versus Intravenous MabThera (Rituximab) in Combination With Chemotherapy in Patients With Chronic Lymphocytic Leukemia

Phase 1 Completed

240 enrolled 27 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00718549 2018-08-20

A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)

128 enrolled 10 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01263704 2018-04-23

A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia

42 enrolled 12 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01271010 2018-03-20

A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status

Phase 4 Terminated

89 enrolled 12 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02013817 2017-08-18

CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy

43 enrolled 9 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00090051 2017-08-01

FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients

552 enrolled 22 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00254163 2016-11-03

Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

184 enrolled 16 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02533401 2016-05-02

A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)

34 enrolled 10 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00410163 2014-02-10

BIFROST

61 enrolled 22 charts

Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00281918 2013-09-19

CLL-8

817 enrolled 18 charts

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00868413 2013-06-07

Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Phase 1 Completed

32 enrolled